Product Safety Recalls

Product Recall Tracker

METFORMIN HYDROCHLORIDE Recall D-0328-2025

Description: Metformin Hydrochloride Extended-Release Tablets 1000mg, 90-count bottle. Manufactured by: Glenmark Pharmaceuticals Limited, Pithampur, Madhya Pradesh 454775, India, Manufactured for: Glenmark Pharmaceuticals Inc. USA, Mahwah, NJ 07430. NDC 68462-521-90.

METFORMIN HYDROCHLORIDE Recall D-0328-2025 Information

StatusOngoing
Mandated?Voluntary: Firm initiated
Recall NumberD-0328-2025
Event ID96474
BrandMETFORMIN HYDROCHLORIDE
Generic NameMETFORMIN HYDROCHLORIDE
ManufacturerMETFORMIN HYDROCHLORIDE
Original Package?1
Active SubstanceMETFORMIN HYDROCHLORIDE
Drug RouteORAL
DistributionU.S. Nationwide
QuantityN/A
Recall ReasonCGMP Deviations
Drug ClassificationClass II
Drug Code Info20250416
Product NDC68462-520 68462-521
Recall Initiation Date20250313
Report Date20250416
Classification Date20250408
Address750 Corporate DrN/A
Mahwah, NJ 07430-2009
United States
Recalling FirmGlenmark Pharmaceuticals Inc., USA
Initial Notification Letter
Unique Ingredient Identifier786Z46389E
Drug Application NumberANDA212969
Structured Product Labeling (SPL ID)ef160cca-85e2-440c-997f-0535914b4d3f
Structured Product Labeling (SPL Set ID)0ef9de1a-b786-4b6c-a250-3f5ac532b16a
Similar To

© 2022 Recall.Report / Contact / Privacy Policy

This site's data is aggregated programmatically and provided "as is" without any representations or warranties, express or implied.
Recall.report is not affiliated with the Consumer Product Safety Commision, FDA, or US government in any way.